Overview
- 338 inspections across 225 sites are on record.
- 284 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-09-10.
At a glance
Inspections
338
Sites
225
Observations
284
Career since
Apr 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Deirdre O. Hooper, M.D. | 10 Sep 2025 | Medical Devices & Rad Health | View 483 → |
| Otsuka Pharmaceutical Development & Commercialization, Inc | 18 Jul 2025 | Human Drugs | |
| Nicolaas C. Geurs, DDS | 27 Jun 2025 | Medical Devices & Rad Health | |
| William T Garvey, M.D. | 5 Jun 2025 | Human Drugs | |
| Southern Research Institute | 14 May 2025 | Biologics |
Sites inspected
Deirdre O. Hooper, M.D.New Orleans, United States1 insp.
Otsuka Pharmaceutical Development & Commercialization, IncRockville, United States1 insp.
Nicolaas C. Geurs, DDSBirmingham, United States1 insp.
William T Garvey, M.D.Birmingham, United States1 insp.
Southern Research InstituteBirmingham, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Fabian N Chaparro-Rodriguez20 shared
Anna E Fain10 shared
Laura L Staples6 shared
Kellie R Riggs5 shared
Koffi A Amegadje4 shared
Deborah A Greco4 shared
Matthew R Mcnew4 shared
Matthew R Coleman3 shared
Daniel L Aisen3 shared
Christopher M Jeffers2 shared
Full investigator report
Get the verbatim findings behind Ann B Borromeo's 284 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site